Hester Biosciences Price Change Analysis
Hester Biosciences Key Statistics
-
P/E Ratio
45.3
-
PEG Ratio
1
-
Market Cap Cr
2013.6
-
Price to Book Ratio
297.3
-
EPS
51.2
-
Dividend
100 ()
-
Relative Strength Index
39.04
-
Money Flow Index
30.38
-
MACD Signal
-43.86
-
Average True Range
118.31
Investment Ratings
-
Master Rating:
-
EPS Strength
Price Strength
Buyer Demand
Group Rank
Result Highlights
Hester Biosciences Synopsis
NSE-Medical-Ethical Drugs
Hester Biosciences L is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 208.48 Cr. and Equity Capital is Rs. 8.51 Cr. for the Year ended 31/03/2021. Hester Biosciences Ltd. is a Public Limited Listed company incorporated on 29/04/1987 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L99999GJ1987PLC022333 and registration number is 022333.-
Market Cap
2,013.61
-
Sales
232.26
-
Shares in Float
-
No of Funds
21
-
Yield
0.42
-
Book Value
8.48
-
U/D Vol Ratio
1.3
-
LTDebt/Equity
1
-
Alpha
-0.08
-
Beta
0.54
Hester Biosciences Ownership
| Owner Name | Jun-21 |
|---|---|
| Promoters | 53.73% |
| Mutual Funds | 0.4% |
| Foreign Portfolio Investors | 0.58% |
| Financial Institutions/ Banks | 0% |
| Individual Investors | 31.89% |
| Others | 13.4% |
Hester Biosciences Management
| Name | Designation |
|---|---|
| Dr. Bhupendra Gandhi | Chairman |
| Mr. Rajiv Gandhi | Managing Director & CEO |
| Mr. Sanjiv Gandhi | Director |
| Mr. Ravin Gandhi | Director |
| Mr. Naman Patel | Independent Director |
| Mr. Amit Shukla | Independent Director |
| Mr. Ashok Bhadakal | Independent Director |
| Mr. Sandhya Patel | Independent Director |
| Ms. Nina Gandhi | Alternate Director |
Hester Biosciences Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Eps And Sales Estimates
Hester Biosciences Financials
- Quarterly P&L
- Annual P&L
- Cash Flow
- Balance Sheet
- Ratios
Hester Biosciences Technicals
EMA & SMA
CURRENT PRICE
EMA
Hester Biosciences Resistance and Support
Hester Biosciences Delivery and Volume
Hester Biosciences Price Change Analysis
Corporate Action
MF Shareholding
| Name | Amount ( in Cr.) |
|---|
Similar Stocks
| Company Name | 52 Week () |
Market Price () | Volume |
|---|
Videos
About Company
News
FAQs
Hester Biosciences share price is